GLP-1 Supplement Safety Guide: What to Take, What to Avoid

✅ Generally Safe Alongside GLP-1 Medications

These supplements have no identified pharmacokinetic interaction with GLP-1 receptor agonists at standard supplemental doses. Individual circumstances may vary.

• Melatonin (0.5–5mg): Separate pathway (MT1/MT2 receptors). Safe alongside all GLP-1 medications. See full semaglutide + melatonin profile →
• Magnesium glycinate/citrate: No GLP-1 pharmacokinetic interaction. May help with sleep and muscle cramping common in GLP-1 patients with reduced dietary intake. Space from Rybelsus by ≥30 min.
• Probiotics: No pharmacokinetic interaction with GLP-1 medications. Some research suggests GLP-1 medications affect gut microbiome; probiotics may be complementary.
• Vitamin B12: Important to monitor on GLP-1 therapy due to potential absorption changes. Supplementation is generally safe and often recommended long-term. Note: compounded tirzepatide mixed with B12 has raised safety concerns — discuss with your physician if using compounded GLP-1 preparations.
• Omega-3 / Fish oil: No significant GLP-1 interaction at standard doses. May complement cardiovascular benefits of GLP-1 therapy in appropriate patients.

🔵 Use With Physician Awareness

• Vitamin D: No direct interaction, but GLP-1 patients are at elevated insufficiency risk due to reduced dietary intake. Monitor levels periodically. See full profile →
• Zinc: At standard doses, safe alongside GLP-1 medications. High doses or zinc on an empty stomach may compound nausea during titration. See full profile →
• Ashwagandha: Mild hypoglycemic and thyroid-stimulating properties require physician awareness, particularly for diabetes patients or those on thyroid medications. See full profile →
• Chromium: Can amplify blood sugar-lowering effects of GLP-1 medications. Low-dose chromium picolinate is commonly used but discuss with your physician, especially for type 2 diabetes management.
• Alpha-lipoic acid (ALA): Has mild blood sugar-lowering properties. Monitor glucose if combining with GLP-1 medications, particularly for diabetes patients.

🔴 Requires Physician Supervision Before Starting

• Berberine: Major interaction. Additive hypoglycemia risk across all GLP-1 medications. Do not start without physician approval and blood glucose monitoring. See full berberine warning guide →
• Cannabis / THC edibles: GLP-1 medications delay gastric emptying, making edible cannabis absorption unpredictably delayed and potentially more intense. Discuss with your prescribing physician. See edibles timing guide →
• St. John's Wort: CYP3A4 inducer that can affect drug metabolism. May be relevant for orforglipron (Foundayo) as a CYP3A4 substrate. Discuss with your physician before combining with any GLP-1 medication.
• High-dose Vitamin C (1,000mg+): May worsen GI side effects during titration. Not a direct pharmacokinetic interaction, but may be poorly tolerated alongside GLP-1 GI effects.

Nutrients to Monitor on Long-Term GLP-1 Therapy

Because GLP-1 medications significantly reduce caloric intake and may affect absorption, the following lab values are worth monitoring periodically on long-term therapy:

• 25-hydroxyvitamin D: Insufficiency is common with reduced dietary fat intake.
• Vitamin B12: Absorption requires stomach acid; monitor particularly if also on a PPI (omeprazole, pantoprazole).
• Ferritin / Iron: Reduced food intake can lead to iron insufficiency over time.
• Magnesium (RBC): Commonly low in patients with reduced dietary intake and active GI symptoms.
• Zinc: May become insufficient with prolonged appetite suppression.

Ask your physician for a comprehensive nutrient panel if you have been on GLP-1 therapy for 6+ months, especially if you are experiencing fatigue, hair loss, or muscle weakness.

Explore Individual Interaction Profiles